This process promotes both proliferation and activation of dendritic cells (DCs) as well as downstream CD8 T-cells, ultimately aiding in the prevention of HCC recurrence and metastasis (Yang et al., 2024). The gene discussed is CD8A; the disease is hepatocellular carcinoma.